| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_160b357d60d1c41ba70004ed9ff7a4ce |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745 |
| filingDate |
2006-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74919b46e12a11665b3f26b257ee6b64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd26e1cd05c586dd2e59ca4e0109131d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0332650382e094ac00561e730144c984
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed420f21e3f70e3c9488e47f8c42ff8b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64a3f575b423b1d17e1765b3ca31cf22 |
| publicationDate |
2008-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2008039485-A1 |
| titleOfInvention |
Low-dose-long-term pharmaceutical composition comprising camptothecin derivatives for the treatment of cancers |
| abstract |
An oral pharmaceutical composition for the treatment of digestive tract cancers contains an effective amount of a camptothecin derivative dissolved in a non-aqueous solvent. The camptothecin derivative is administered at a dose of about 0.05 to about 1 mg/kg body weight/day. The pharmaceutical composition is particularly suitable for use in low-dose-long-term regimens for colorectal cancers. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3866783-A4 |
| priorityDate |
2006-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |